- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 5.25M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 5.03M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $814K |
| Capex | Q1 2024 · Mar 31, 2023 | $5.08M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$48.83M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$29.47M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $0 |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $0 |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$882.22M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$347.97M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $267M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $1.42B |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $2.05B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.55B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $255.08M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $182.82M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.05B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.01B |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$91.10 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$12.03 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$90.46 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$11.74 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $89.11M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $96.47M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$415.71M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$28.15M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$111.11M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$39.53M |
| Revenue | Q1 2024 · Mar 31, 2024 | $684.43M |
| Revenue | Q1 2024 · Mar 31, 2023 | $866.91M |